Predict your next investment

HEALTHCARE | Drug Development
aicorp.com

See what CB Insights has to offer

Founded Year

1986

Stage

Acq - P2P | Acquired

Total Raised

$20.41M

Valuation

$0000 

Revenue

$0000 

About Applied Imaging

Applied Imaging was a Healthcare/Drug Development company based in San Jose, California. Applied Imaging was acquired in 2006.

Applied Imaging Headquarter Location

120 Baytech Drive

San Jose, California, 95134,

United States

408-719-6400

Latest Applied Imaging News

Insights on the Cancer Diagnostics Global Market to 2027 - Featuring Applied Imaging, AstraZeneca & Bayer Among Others

Sep 28, 2020

| Source: Research and Markets Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 7th edition of this report. The 308-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Cancer Diagnostics Market to Reach $223.3 Billion by 2027 Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150.6 Billion in the year 2020, is projected to reach a revised size of US$223.3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period. The U.S. Market is Estimated at $40.8 Billion, While China is Forecast to Grow at 8.8% CAGR The Cancer Diagnostics market in the U.S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR. Imaging Segment to Record 6.2% CAGR In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. Competitors identified in this market include, among others: Abbott Diagnostics Bayer AG

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.